The Literature

» disease/medicine and immunology

Most Recent

image: Breaching the Wall

Breaching the Wall

By | December 1, 2011

Editor’s choice in immunology

0 Comments

image: Piggyback Pathogen

Piggyback Pathogen

By | September 1, 2011

Editor’s Choice in Immunology

0 Comments

image: Hiding Under a Cap

Hiding Under a Cap

By | August 30, 2011

Editor's Choice in Immunology

0 Comments

image: An Eyeful of RNA

An Eyeful of RNA

By | August 1, 2011

Editor's Choice in Physiology

3 Comments

image: Thymus Finder

Thymus Finder

By | July 1, 2011

Editor’s Choice in Immunology

0 Comments

image: Approaching Universality

Approaching Universality

By | June 5, 2011

Pitfalls and triumphs on the way to complete vaccine protection.

6 Comments

image: Compact Model T

Compact Model T

By | May 25, 2011

Editor's choice in immunology

0 Comments

image: The Heart of the Matter

The Heart of the Matter

By | April 1, 2011

Are miRNAs useful for tracking and treating cardiovascular disease?

0 Comments

image: Viral Hijackers

Viral Hijackers

By | April 1, 2011

Editor's choice in immunology

0 Comments

image: Model Liver

Model Liver

By | April 1, 2011

Editor's choice in physiology

0 Comments

Popular Now

  1. UC Berkeley Receives CRISPR Patent in Europe
    Daily News UC Berkeley Receives CRISPR Patent in Europe

    The European Patent Office will grant patent rights over the use of CRISPR in all cell types to a University of California team, contrasting with a recent decision in the U.S.

  2. DNA Replication Errors Contribute to Cancer Risk
  3. Should Healthy People Have Their Exomes Sequenced?
    Daily News Should Healthy People Have Their Exomes Sequenced?

    With its announced launch of a whole-exome sequencing service for apparently healthy individuals, Ambry Genetics is the latest company to enter this growing market. But whether these services are useful for most people remains up for debate.  

  4. Rethinking a Cancer Drug Target
    Daily News Rethinking a Cancer Drug Target

    The results of a CRISPR-Cas9 study suggest that MELK—a protein thought to play a critical role in cancer—is not necessary for cancer cell survival.

Business Birmingham